Mutational analysis of G-protein coupled receptor - FFA2

Biochemical and Biophysical Research Communications

Volumn 405, Issue 1, 2011, Pages 122-127

  Swaminath, Gayathri ^a   Jaeckel, Peter ^b   Guo, Qi ^a   Cardozo, Mario ^a   Weiszmann, Jennifer ^a   Lindberg, Richard ^a   Wang, Yingcai ^a   Schwandner, Ralf ^b   Li, Yang ^a  

^a AMGEN INC   (United States)

^b Amgen Research GmbH   (Germany)

Author keywords

Allosteric agonist; AMG7703; FFA2; FFAR2; GPR43; Short chain fatty acids

Indexed keywords

ACETANILIDE; FREE FATTY ACID RECEPTOR 2; G PROTEIN COUPLED RECEPTOR; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; BINDING SITE; CELL STRAIN HEK293; IN VITRO STUDY; MOLECULAR MODEL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN INTERACTION;

ALLOSTERIC REGULATION; ANIMALS; BINDING SITES; DNA MUTATIONAL ANALYSIS; HEK293 CELLS; HUMANS; LIGANDS; MUTAGENESIS; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE;

EID: 79551491907     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.139     Document Type: Article

References (22)

1. Sawzdargo M., George S.R., Nguyen T., Xu S., Kolakowski L.F., O'Dowd B.F. A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochem. Biophys. Res. Commun. 1997, 239:543-547.
2. Wise A., Jupe S.C., Rees S. The identification of ligands at orphan G-protein coupled receptors. Annu. Rev. Pharmacol. Toxicol. 2004, 44:43-66.
3. Lundstrom K. Latest development in drug discovery on G protein-coupled receptors. Curr. Protein Pept. Sci. 2006, 7:465-470.
4. Covington D.K., Briscoe C.A., Brown A.J., Jayawickreme C.K. The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing. Biochem. Soc. Trans. 2006, 34:770-773.
5. Stoddart L.A., Smith N.J., Milligan G. International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol. Rev. 2008, 60:405-417.
6. Rayasam G.V., Tulasi V.K., Davis J.A., Bansal V.S. Fatty acid receptors as new therapeutic targets for diabetes. Expert Opin. Ther. Targets 2007, 11:661-671.
7. Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., Muir A.I., Wigglesworth M.J., Kinghorn I., Fraser N.J., Pike N.B., Strum J.C., Steplewski K.M., Murdock P.R., Holder J.C., Marshall F.H., Szekeres P.G., Wilson S., Ignar D.M., Foord S.M., Wise A., Dowell S.J. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003, 278:11312-11319.
8. Nilsson N.E., Kotarsky K., Owman C., Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem. Biophys. Res. Commun. 2003, 303:1047-1052.
9. Le Poul E., Loison C., Struyf S., Springael J.Y., Lannoy V., Decobecq M.E., Brezillon S., Dupriez V., Vassart G., Van Damme J., Parmentier M., Detheux M. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 2003, 278:25481-25489.
10. Ge H., Li X., Weiszmann J., Wang P., Baribault H., Chen J.-L., Tian H., Li Y. Activation of GPR43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 2008, 149:4519.
11. Swaminath G. Fatty acid binding receptors and their physiological role in type 2 diabetes. Arch. Pharm. (Weinheim) 2008, 341:753-761.
12. Nagasumi K., Esaki R., Iwachidow K., Yasuhara Y., Ogi K., Tanaka H., Nakata M., Yano T., Shimakawa K., Taketomi S., Takeuchi K., Odaka H., Kaisho Y. Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. Diabetes 2009, 58:1067-1076.
13. Tikhonova I.G., Sum C.S., Neumann S., Thomas C.J., Raaka B.M., Costanzi S., Gershengorn M.C. Bidirectional, iterative approach to the structural delineation of the functional " chemoprint" in GPR40 for agonist recognition. J. Med. Chem. 2007, 50:2981-2989.
14. Sum C.S., Tikhonova I.G., Neumann S., Engel S., Raaka B.M., Costanzi S., Gershengorn M.C. Identification of residues important for agonist recognition and activation in GPR40. J. Biol. Chem. 2007, 282:29248-29255.
15. Stoddart L.A., Smith N.J., Jenkins L., Brown A.J., Milligan G. Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids. J. Biol. Chem. 2008, 283:32913-32924.
16. Swaminath G., Jaeckel P., Guo Q., Cardozo M., Weiszmann J., Lindberg R., Wang Y., Schwandner R., Li Y. Allosteric rescuing of loss-of-function FFA2 mutations. FEBS Lett. 2010, 584:4208-4214.
17. Lee T., Schwandner R., Swaminath G., Weiszmann J., Cardozo M., Greenberg J., Jaeckel P., Ge H., Wang Y., Jiao X., Liu J., Kayser F., Tian H., Li Y. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol. Pharmacol. 2008, 74:1599-1609.
18. Wang Y., Jiao X., Kayser F., Liu J., Wang Z., Wanska M., Greenberg J., Weiszmann J., Ge H., Tian H., Wong S., Schwandner R., Lee T., Li Y. The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators. Bioorg. Med. Chem. Lett. 2010, 20:493-498.
19. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., Stevens R.C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
20. N.J. Smith, L.A. Stoddart, N.M. Devine, L. Jenkins, G. Milligan, The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1, J. Biol. Chem. (2009).
21. Langmead C.J., Christopoulos A. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox. Trends Pharmacol. Sci. 2006, 27:475-481.
22. May L.T., Leach K., Sexton P.M., Christopoulos A. Allosteric modulation of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 2007, 47:1-51.